Trial Profile
Cerebrolysin and Recovery after Stroke (CARS) - A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Clinical Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms CERE-REHA-1
- Sponsors EVER Neuro Pharma
- 20 Jan 2017 New trial record